Frequency and characterization of RHD variants in serologically D- Surinamese pregnant women and D- newborns

Transfusion. 2019 Aug;59(8):2672-2677. doi: 10.1111/trf.15394. Epub 2019 Jun 10.

Abstract

Background: Numerous RHD variant genes affect the expression of D on the red blood cell surface. In Suriname, 4.3% of pregnant women were D-, ranging from virtually zero to 7% among ethnic groups. Characterization of RHD variants, which are associated with a variable potential to induce anti-D, is of practical clinical importance especially in case of limited access to preventive measures. Here we report on the occurrence of RHD variant genes in Surinamese serologically D- pregnant women and their D- newborns from different ethnic groups.

Study design and methods: The RheSuN study is a cross-sectional cohort study in D- pregnant women and their newborns, who visited hospitals in Paramaribo, Suriname, during routine pregnancy care. The presence of RHD variants was investigated using quantitative polymerase chain reaction targeting RHD Exons 5 and 7 and RH-multiplex ligation-dependent probe amplification.

Results: Seven RHD variant genes were detected in 35 of 84 women and four RHD variant genes in 15 of 36 newborns. The RHD*03 N.01 and RHD*08 N.01 variants represented 87% of a total of 62 variant genes. Variants were comparably frequent among ethnicities. In four cases genotyping would have changed anti-D prophylaxis policy: one woman with a RHD*01EL.01 variant, not associated with anti-D formation and three D- newborns with RHD*09.01 and RHD*09.03.01 variants, potentially capable of inducing anti-D.

Conclusion: RHD variants at risk for anti-D are common among serologic D- individuals from African descent in Suriname. While genotyping D- women has limited added value, it may be considered in newborns from D- women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Erythroblastosis, Fetal / blood
  • Erythroblastosis, Fetal / genetics
  • Exons*
  • Female
  • Genetic Variation*
  • Humans
  • Infant, Newborn
  • Ligase Chain Reaction
  • Pregnancy
  • Real-Time Polymerase Chain Reaction
  • Rh-Hr Blood-Group System / blood
  • Rh-Hr Blood-Group System / genetics*
  • Risk Factors
  • Suriname

Substances

  • Rh-Hr Blood-Group System
  • Rho(D) antigen